Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
65.67
-1.85 (-2.74%)
At close: Aug 28, 2026, 4:00 PM EDT
65.21
-0.46 (-0.70%)
Pre-market: Aug 31, 2026, 5:11 AM EDT

Travere Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
117.7493.0458.5458.1861.69165.75
Short-Term Investments
371.44229.76312.17508.68388.56387.13
Cash & Short-Term Investments
489.18322.8370.7566.85450.25552.88
Cash Growth
53.09%-12.92%-34.60%25.90%-18.56%52.90%
Accounts Receivable
80.6480.1327.1221.1816.6515.91
Other Receivables
2.31.32.34.61.90.9
Receivables
82.9481.4329.4225.7818.5516.81
Inventory
7.845.886.29.414.527.31
Prepaid Expenses
35.1927.4610.3914.7410.135.82
Other Current Assets
----2.99-
Total Current Assets
615.14437.57416.7616.78486.44582.83
Property, Plant & Equipment
11.9814.619.6325.5430.0534.3
Goodwill
0.750.750.750.750.750.94
Other Intangible Assets
130.77113.12103.22103.6996.32147.5
Other Long-Term Assets
40.7339.1653.8242.1659.0311.07
Total Assets
799.36605.19594.13788.91672.59776.63

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
7.524.823.5341.6817.2915.14
Accrued Expenses
136.27126.0486.03107.5795.7475.18
Current Portion of Long-Term Debt
--68.68---
Current Portion of Leases
6.165.885.414.914.433.91
Current Unearned Revenue
--2.827.111.9816.27
Other Current Liabilities
2.13.1914.2916.6612.7213.59
Total Current Liabilities
152.03159.9200.75177.91142.16124.09
Long-Term Debt
602.78311.72310.31377.26375.55226.58
Long-Term Leases
7.9611.1317.1922.6127.5131.5
Long-Term Unearned Revenue
---1.8410.9320.38
Other Long-Term Liabilities
12.077.66.88.4973.5971.98
Total Liabilities
774.84490.36535.05588.1629.73474.52

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.010.010.010.010.01
Additional Paid-In Capital
1,5701,5891,5061,3281,0601,069
Retained Earnings
-1,545-1,473-1,447-1,126-1,014-765.97
Comprehensive Income & Other
-1.12-1.19-0.08-1.46-2.91-0.56
Shareholders' Equity
24.52114.8359.08200.8142.85302.11
Total Liabilities & Equity
799.36605.19594.13788.91672.59776.63

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
616.91328.73401.58404.78407.49261.99
Net Cash (Debt)
-127.73-5.94-30.88162.0742.76290.9
Net Cash Growth
---279.04%-85.30%147.45%
Net Cash Per Share
-1.40-0.07-0.392.180.674.86
Filing Date Shares Outstanding
94.2692.2488.7476.164.7463.21
Total Common Shares Outstanding
94.1790.9287.4575.3764.2962.49
Working Capital
463.12277.66215.95438.87344.27458.74
Book Value Per Share
0.261.260.682.660.674.83
Tangible Book Value
-1070.96-44.996.37-54.22153.68
Tangible Book Value Per Share
-1.140.01-0.511.28-0.842.46
Machinery
-5.134.725.064.994.73
Construction In Progress
---0.170.080.63
Leasehold Improvements
-8.999.379.699.188.79
SEC Filings: 10-K · 10-Q